TCTR20210904004
Not yet recruiting
Phase 1
A Pilot Study: Safety and Immunological Response following Intradermal COVID-19 vaccination with Accelerate Regimen
Health Systems Research Institute (HSRI)0 sites60 target enrollmentSeptember 4, 2021
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Healthy volunteer
- Sponsor
- Health Systems Research Institute (HSRI)
- Enrollment
- 60
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Males or females at least 18\-60 years of age (inclusive)
- •2\. Have not received any COVID\-19 vaccine?
- •3\. Can understand Thai language through speaking, reading and writing?
- •4\. Able to communicate through electronic tools such as Google form or line?
- •5\. Capable of attending all study visits according to the study schedule.
- •6\. Capable of informed consent and provision of written informed consent before any study procedures.
Exclusion Criteria
- •1\. Have history of severe drug or vaccine allergy (anaphylaxis)?
- •2\. Have detected COVID\-19 infection?
- •3\. Have history of COVID\-19 high risk contact?
- •4\. Have history of Chronic respiratory disease, CVD, CKD, CVS, obesity, cancer and DM?
- •5\. Positive result(s) from either antigen test kit.
- •6\. Have received blood transfusion, plasma, blood product, blood component, immunoglobilins, antiviral or antibodies within the last 90 days?
- •7\. Have history of cigarettes smoking, alcohol drinking and history of drug abuse?
- •8\. Being pregnant?
- •9\. have unstable disease or could not control the sysptom?
- •10\. Have history of immunodeficiency or been using immunosuppressant or steriod drugs?
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 1
A Pilot Study: Safety and Immunological Response following Intradermal COVID-19 vaccination in The Booster (3rd dose)healthy volunteerSafety and Immunological Response Intradermal COVID-19 vaccinationTCTR20210907003Faculty of Medicine Siriraj Hospital, Mahidol University60
Not yet recruiting
Phase 1
A Pilot Study: Safety and Immunological Response following Intradermal COVID-19 vaccinatiohealthy volunteerSafety and Immunological ResponseIntradermalCOVID-19 vaccinationTCTR20210903006Faculty of Medicine Siriraj Hospital, Mahidol University80
Recruiting
Phase 2
Preliminary study: Safety and Immunological Response following COVID-19 Vaccination in COVID-19 survivorsCOVID-19 survivorsCOVID-19 VaccinationTCTR20210720005Faculty of Medicine Siriraj Hospital180
Active, not recruiting
Not Applicable
Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and ChildreJapanese EncephalitisTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2015-005193-38-Outside-EU/EEASanofi Pasteur SA300
Recruiting
Phase 1
A pilot study to evaluate the safety and efficacy of a personalised cancer vaccine in patients with completely resected early stage lung cancerACTRN12619000769189niversity of Western Australia6